LORBRENA vs SIROLIMUS

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. LORBRENA and SIROLIMUS are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	LORBRENA	SIROLIMUS
Rating	64/100	66/100
Pharmacy pays	—	~$48.61 /30
Type	RX	RX
Active ingredient	LORLATINIB	SIROLIMUS
Manufacturer	Pfizer	Apotex
Dosage forms	Tablet	Solution
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	Boxed warning
Treats	—	Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

lorbrena sirolimus

Rating

64/100

66/100

Pharmacy pays

—

~$48.61 /30

Type

Active ingredient

LORLATINIB

SIROLIMUS

Manufacturer

Pfizer

Apotex

Dosage forms

Tablet

Solution

Drug class

Kinase Inhibitor

Boxed warning

None

Boxed warning

Treats

—

Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

Frequently asked questions

Which is better-rated, Lorbrena or Sirolimus?

By our independent rating, Sirolimus scores higher — 3.3 vs 3.2 out of 5 for Lorbrena. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Lorbrena and Sirolimus?

Lorbrena contains Lorlatinib, while Sirolimus contains Sirolimus — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.